LIPO P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.64
Average-0.6871
Median-0.7100
Minimum-0.7500
Maximum-0.5300
-0.64
Past Month-0.06 (10.34%)
The P/E ratio for LIPO is -0.64 as of Jun 13, 2025. This represents a decrease of -9.86% compared to its 12-month average P/E ratio of -0.71. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Lipella Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lipella Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lipella Pharmaceuticals Inc to industry peers.
Lipella Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lipella Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lipella Pharmaceuticals Inc to industry peers.
LIPO P/E Ratio Insights
See Lipella Pharmaceuticals Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in LIPO
Order type
Buy in
Order amount
Est. shares
0 shares
LIPO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $2.945 | -0.72 |
| May 1, 2025 | $2.52 | -0.53 |
| Apr 1, 2025 | $2.57 | -0.54 |
| Mar 3, 2025 | $2.81 | -0.63 |
| Feb 3, 2025 | $2.73 | -0.61 |
| Jan 2, 2025 | $3.18 | -0.71 |
LIPO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.64 | -5.88% |
| 2024 | -0.68 | -50.36% |
| 2023 | -1.37 | -80.06% |
| 2022 | -6.87 | — |
FAQs About Lipella Pharmaceuticals Inc (LIPO) P/E ratio
The latest P/E ratio of LIPO is -0.64, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Lipella Pharmaceuticals Inc’s last 12-month average P/E ratio is -0.71, compared to its current P/E ratio of -0.64. This reflects a decrease of -9.86%.
Lipella Pharmaceuticals Inc’s current P/E ratio of -0.64 is lower than its last 12-month average P/E of -0.71. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Lipella Pharmaceuticals Inc’s average P/E ratio over the last 3 years is -1.92. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Lipella Pharmaceuticals Inc’s average P/E ratio over the last 5 years is -1.15. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.